'Generic HIV antiretroviral sales to more than double to$1.2-bn in 2019'

摘要

According to a new report from UK-based market research firm, Datamoni-tor, generic HIV antiretroviral drug sales will more than double to $1.2-bn in 2019. Half of all antiretroviral sales in 2019 will be attributed to current pipeline products, as fixed dose combinations increase in dominance over the next decade, Datamonitor added.